Dow Jones Futures Rise: Boeing, Biden, France In Focus; Tesla, Amazon In Buy Zones
President Biden's campaign future and French elections are market wildcards. Tesla and Amazon lead stocks in buy zones.
President Biden's campaign future and French elections are market wildcards. Tesla and Amazon lead stocks in buy zones.
The EV giant delivered 443,956 vehicles during the second quarter, versus an analyst consensus estimate of 439,302 deliveries.
VICTOR, N.Y., July 02, 2024--Broadstone Net Lease Provides an Update on its Healthcare Portfolio Simplification Strategy and Schedules Second Quarter 2024 Earnings
BOSTON, July 02, 2024--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 123,500 shares of Astria’s common stock on July 1, 2024 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria.
Novo Nordisk stock fell Tuesday after Joe Biden and Bernie Sanders slammed the drugmaker and Eli Lilly for high prices of weight-loss drugs.
Cartesian Therapeutics reported a "watershed moment" for its autoimmune-disease drug on Tuesday, but the biotech stock plunged.
Yahoo Sports' Jason Fitz and Frank Schwab discuss how Philadelphia's defense will dictate how successful the Eagles will be this season. Listen and subscribe to the “Zero Blitz” podcast on Apple Podcasts, Spotify or wherever you listen.
Bob Good tried to make amends with trip to New York to support Trump in court, but ultimately failed
Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.
General Motors grew auto sales modestly in the second quarter, but its EV sales jumped double digits. Ford is on tap.
Shares of Archer Aviation (ACHR) are soaring on the news that Stellantis (STLA) is investing $55 million more into the electric aviation company. Josh Lipton and Seana Smith report more on the investment and Archer Aviation's outlook. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
LANCASTER, Calif., July 02, 2024--Simulations Plus today reported 3QFY24 total revenue of $18.5 million, up 14% over 3QFY23, and 9 months FY24 total revenue of $51.3 million, up 17%.
Oprah Winfrey is reflecting on feeling like she "should be shamed" after Joan Rivers told her to lose 15 pounds on "The Tonight Show."
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditure Associated with Three-Year Expansion Program Completed -- -- FY 2025 Revenue Guidance of Between $160 Million and $168 Million -- TUSTIN, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedic
DALLAS, July 02, 2024--NETSTREIT Corp. (the "Company"), a nationwide owner of high-quality, single-tenant net lease properties, today announced that it will release its second quarter 2024 financial results on July 29, 2024 after the close of trading on the New York Stock Exchange. A conference call will be held on Tuesday, July 30, 2024 at 11:00 AM ET.
LOUISVILLE, Ky., July 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2024 financial results on Friday, August 2, 2024, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on th
Dr. Malik to deepen strategic leadership and provide regulatory and clinical development innovation expertiseGAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced the appointment of Kemal Malik, MBBS to its Board of Directors. Dr. Malik brings to Cartesian over 30 years of global development, regulatory, and commercial expertise
Conference Call Wednesday, July 24th, at 11:00 A.M.RALEIGH, N.C., July 02, 2024 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) will release its second quarter 2024 results on Tuesday, July 23rd, after the market closes. A conference call will be held the next day, Wednesday, July 24th, at 11:00 A.M. Eastern time. For US/Canada callers, dial (833) 470-1428 and enter access code 794414. International callers should dial (929) 526-1599 and enter the same passcode. A live, listen-only web
MIAMI, July 02, 2024 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) declares its monthly distribution for July 2024 of $0.08 per share, payable on August 1, 2024 to stockholders of record as of July 15, 2024. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic report f
LAS VEGAS, July 02, 2024--Light & Wonder, Inc. (NASDAQ and ASX: LNW) ("Light & Wonder" or the "Company"), announced today it will release its financial results for the second quarter of 2024, on Wednesday, August 7, 2024, after market close. The Company will host an investor conference call and simultaneous webcast the same day at 4:30 p.m. U.S. Eastern Time to discuss the results.
BROOKFIELD, NEWS, July 02, 2024 (GLOBE NEWSWIRE) -- Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) (“Brookfield Renewable”) today announced that Brookfield Renewable Power Preferred Equity Inc. (“BRP Equity”) has determined the fixed dividend rate on its Class A Preference Shares, Series 3 (“Series 3 Shares”) (TSX: BRF.PR.C) for the five years commencing August 1, 2024 and ending July 31, 2029. Series 3 Shares and Series 4 Shares If declared, the fixed quarterly dividends on the Ser